Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Microbiology|December 9, 2014
Ten years of pan-genome analysesGeorge Vernikos, Duccio Medini, David R Riley, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 8, 2023
Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical ManagementFrank G Preston, David R Riley, Shazli Azmi, et al.
Mbio|July 24, 2014
Parallel evolution of Streptococcus pneumoniae and Streptococcus mitis to pathogenic and mutualistic lifestylesMogens Kilian, David R Riley, Anders Jensen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2026
Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri-Menopausal MASLDAlex E Henney, Jo Wilson, David R Riley, et al.
Bioinformatics (Oxford, England)|November 29, 2011
Using Sybil for interactive comparative genomics of microbes on the webDavid R Riley, Samuel V Angiuoli, Jonathan Crabtree, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 22, 2025
Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 DiabetesAlex E Henney, David R Riley, Matthew Anson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2024
The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomesDavid R Riley, Theresa Hydes, Gema Hernadez, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 DiabetesWeronika Stupalkowska, Alex E Henney, David R Riley, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 3, 2017
Diabetic Neuropathy and Gait: A ReviewUazman Alam, David R Riley, Ravinder S Jugdey, et al.
Diabetes, Obesity & Metabolism|August 7, 2024
Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort dataAlex E Henney, David R Riley, Megan Heague, et al.
Pageof 5